AI assistant
Sending…
Microbot Medical Inc. — Director's Dealing 2015
Mar 25, 2015
33819_dirs_2015-03-25_88e397da-2e71-4080-a60d-def3d5e538fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2015-03-23
Reporting Person: Massey Ian J (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-23 | Common Stock | A | 750000 | $0.00 | Acquired | 750000 | Direct |
Footnotes
F1: Restricted stock units with performance based vesting set by the issuer's Board of Directors and tied to the timely and successful conduct and completion of the issuer's Phase II clinical studies in dry AMD and spinal cord injury.
F2: Consists of 750,000 restricted stock units with performance based vesting.
More from Microbot Medical Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 10